WellGen logo — Pioneering the intersection of nutrition and medicine throug...

WellGen

Pioneering the intersection of nutrition and medicine through innovative bioinformatics and nutrigenomics expertise.

Founded 1997 2-10 employees Series C Total: $16.50M Biotechnology, Health Care +3

General Information

Company Name WellGen
Founded Year 1997
Employees 2-10
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with WellGen. To contact WellGen, visit wellgen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About WellGen

WellGen is a pioneering biotechnology firm founded in 1997, specializing in the intersection of nutrition and medicine. The company's flagship product, Alignomx™, is a bioinformatics model harnessing nutrigenomics to identify therapeutic areas for their unique natural products. Backed by a $9.50M Series C investment from Amphion Innovations, WellGen is strategically positioned in the biotechnology and information technology industries, with a focus on developing exclusive medical foods and pursuing opportunities in functional food and beverage markets. WellGen's expertise in nutrigenomics and natural product chemistry gives them a competitive edge in creating innovative solutions for the healthcare and nutrition sectors. As a portfolio company of Amphion Innovations (LSE: AMP), WellGen has the financial and strategic backing necessary to continue their groundbreaking work at the nexus of science and nutrition.

Taxonomy: nutrigenomics, bioinformatics, gene expression data, medical foods, natural products, functional food and beverage, dietary supplements, pharmaceuticals, Amphion Innovations, proprietary, nutritional medicine, innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $9.50M 1
Amphion Innovations
29 Oct 2007
Series B $3.00M 1
Amphion Innovations
16 Feb 2006
Venture Round $1.00M -
04 Nov 2005
Venture Round $3.00M 1
Amphion Innovations
25 Mar 2004
Venture Round Undisclosed 1
Danisco Venture
12 Dec 2001

WellGen Alternatives & Competitors

View All Alternatives
WellGen vs
Brightseed
Brightseed United States

The Bioactives Company

Series B
36 employees
AI, Biotechnology
WellGen vs
For Wellness
For Wellness United States

Celebrating people on their journey to wellness.

12 employees
E-Commerce, Food and Beverage
WellGen vs
BioActor
BioActor The Netherlands

Living Life Science

Series A
20 employees
Biotechnology, Health Care

FAQ About WellGen

Pioneering the intersection of nutrition and medicine through innovative bioinformatics and nutrigenomics expertise.
WellGen was founded in 1997.
WellGen operates in Biotechnology, Health Care, Health and Wellness, Information Technology and Telecom. Its work centres on nutrigenomics, bioinformatics, gene expression data and medical foods.
WellGen has approximately 2-10 employees.
WellGen has completed 5 funding rounds, raising a total of $16.50M. The latest funding stage is Series C.
Top alternatives and competitors to WellGen include Brightseed, For Wellness, BioActor, MARNYS - Martínez Nieto, S.A., Disruptive Enterprises, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WellGen and Brightseed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WellGen, https://bouncewatch.com/company/wellgen, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes